Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Randy M, Stalter"'
Autor:
Sixtine O. Gurrey, Lara B. Strick, Lana K. Dov, James S. Miller, Monica Pecha, Randy M. Stalter, David L. Miller, Brandon Marshall, Alonso Pezo Salazar, Laura P. Newman
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 13, Pp 17-20 (2024)
The large COVID-19 outbreaks in prisons in the Washington (USA) State Department of Corrections (WADOC) system during 2020 highlighted the need for a new public health approach to prevent and control COVID-19 transmission in the system’s 12 facilit
Externí odkaz:
https://doaj.org/article/efa5105f3c3e417b9f24a34cd62fbb54
Autor:
Randy M. Stalter, Monica Pecha, Lana Dov, David Miller, Zainab Ghazal, Jonathan Wortham, Sandy Althomsons, Molly Deutsch-Feldman, Rebekah Stewart, Derrick Felix, Sophia Hsu, Lara B. Strick
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:309-312
Autor:
Yasaman Zia, Lydia Nambala, Randy M. Stalter, Timothy R. Muwonge, Timothy Ssebuliba, Agnes Nakyanzi, Olivia Nampewo, Jade Boyer, Susan Morrison, Rogers Nsubuga, Monica Bagaya, Robert Nyanzi, Flavia Matovu, Michael Yin, Christina Wyatt, Andrew Mujugira, Renee Heffron
Publikováno v:
AIDS Care. :1-10
Autor:
Jennifer Velloza, Andrew Mujugira, Timothy Muwonge, Jade Boyer, Olivia Nampewo, Josephine Badaru, Timothy Ssebuliba, Randy M. Stalter, Gabrielle Stein, Jared M. Baeten, Connie Celum, Renee Heffron
Publikováno v:
AIDS and Behavior. 27:279-289
Low perceived HIV risk is a barrier to effective pre-exposure prophylaxis (PrEP) use among African adolescent girls and young women (AGYW). Single-item risk perception measures are stigmatizing and alienating to AGYW and may not predict PrEP use. The
Autor:
Vidya L. Atluri, Randy M. Stalter, Sarah A. McGuffin, Luke Johnson, Bailey Healy, Hailey A. Benesch, Kristine Lan, Paula Marsland, Paul Pottinger, Rena C. Patel
Publikováno v:
Journal of Medical Virology. 94:4792-4802
Accurate diagnosis of coronavirus disease 2019 is essential to limiting transmission within healthcare settings. The aim of this study was to identify patient demographic and clinical characteristics that could impact the clinical sensitivity of the
Autor:
Donna R McCarraher, Catherine Packer, Sarah Mercer, Alexis Dennis, Harry Banda, Namakau Nyambe, Randy M Stalter, Jonathan K Mwansa, Patrick Katayamoyo, Julie A Denison
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197853 (2018)
BACKGROUND:Understanding and meeting the reproductive health needs of adolescents living with HIV (ALHIV) is a growing concern since advances in antiretroviral therapy mean that many ALHIV are now living into adulthood and starting to have sex. METHO
Externí odkaz:
https://doaj.org/article/84bd0485821e47169d0026393e0b2d5a
Autor:
Randy M Stalter, Jenae Tharaldson, Derek H Owen, Eunice Okumu, Thomas Moench, Natasha Mack, Elizabeth E Tolley, Kathleen M MacQueen
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180963 (2017)
Results of recent microbicide and pre-exposure prophylaxis clinical trials have shown adherence to be a significant challenge with new HIV prevention technologies. As the vaginal ring containing dapivirine moves into two open label follow-on studies
Externí odkaz:
https://doaj.org/article/88d44e01cae04511baf59c2f6bf943eb
Publikováno v:
Expert Opin Drug Saf
INTRODUCTION: Pregnancy is a period of elevated HIV risk in high-burden settings, motivating the need for prevention tools that are both safe for use and effective during pregnancy. Oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil
Autor:
Randy M, Stalter, Gustavo, Amorim, A Rain, Mocello, Beatrice, Jakait, Bryan E, Shepherd, Beverly, Musick, Caitlin, Bernard, Elizabeth A, Bukusi, Kara, Wools-Kaloustian, Craig R, Cohen, Constantin T, Yiannoutsos, Rena C, Patel
Publikováno v:
Journal of the International AIDS Society. 25(9)
Contraceptive implants containing etonogestrel and levonorgestrel have emerged as popular contraceptive options among women in areas of high HIV burden in sub-Saharan Africa. However, recent pharmacokinetic data have shown drug-drug interactions betw
Autor:
Randy M Stalter, Thomas R Moench, Kathleen M MacQueen, Elizabeth E Tolley, Derek H Owen, for the Consortium for Ring Adherence
Publikováno v:
Journal of the International AIDS Society, Vol 19, Iss 1, Pp n/a-n/a (2016)
Introduction Poor adherence to product use has been observed in recent trials of antiretroviral (ARV)‐based oral and vaginal gel HIV prevention products, resulting in an inability to determine product efficacy. The delivery of microbicides through
Externí odkaz:
https://doaj.org/article/a9c1ca96e9de44e7b8cb6e083d7e9f96